A Phase 1/2 Randomized Study to Evaluate the Safety Tolerability Immunogenicity and Immunopersistence of a Clostridioides Difficile Vaccine Administered with Novel Adjuvants in Healthy Adults

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Clostridium Difficile
  • Age: Between 65 Year(s) - 110 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Healthy adult
    2. 65 years of age or older
    3. Agree to comply with all study requirements

You may not be eligible for this study if the following are true:

    1. History of severe reaction associated with a vaccine
    2. Immunocompromised individuals with known or suspected Immunodeficiency
    3. Previously received an investigational Clostridioides difficile (C. diff) vaccine or C. diff monoclonal antibody therapy
    4. Have had a confirmed episode of C. diff infection



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.